Jalpa A. Doshi, PhD, is Professor of Medicine at the University of Pennsylvania Perelman School of Medicine. She is also Director of Value Based Insurance Design Initiatives at the Center for Health Incentives and Behavioral Economics and Director of the Economic Evaluations Unit of the Center for Evidence-based Practice at Penn.
The goal of her research program is to understand how pharmaceuticals can be better accessed and utilized in the health care system to improve health care quality while balancing costs. Her research focuses on three broad areas. First, it examines the impact of prescription benefit design and reimbursement policies on access to prescription drugs, and the quality and cost of health care. Second, her work focuses on the prevalence, causes, outcomes, and costs of suboptimal medication use in chronic diseases and the clinical and economic impact of innovative behavioral or policy interventions for improving medication adherence and management. Third, her research focuses on advancing the methods used in pharmaceutical outcomes and cost-effectiveness research to enhance its usefulness in real world decision-making by patients, providers, payers, and policymakers. In recent years, her research program in all three areas has focused on specialty drugs, which have become increasingly important treatment options for patients with serious, rare, and/or chronic diseases.
Dr. Doshi has extensive experience working with data from administrative claims, electronic medical records, surveys, registries, and randomized clinical trials. She has also co-authored Economic Evaluation in Clinical Trials (Oxford University Press), the first book dedicated entirely to this topic. Her research has received widespread attention from the media, including the New York Times and Wall Street Journal, and has informed policies of private insurers and government programs. Her work has been recognized by numerous prestigious awards from multiple national and international organizations such as the American Geriatrics Society, American Heart Association, AcademyHealth, Drug Information Association, and the International Society for Pharmacoeconomics and Outcomes Research. She is frequently invited to teach international audiences in Asia, Europe, and North America. She has previously served as co-editor of the Value in Health journal and guest editor for its special issue on Value Assessment Frameworks, published in 2017. She currently serves as an associate editor of the Health Economics journal. Dr. Doshi also serves on the Board of Directors (2018-21) of the International Society for Pharmacoeconomics and Outcomes Research.